Company Search:
Advanced Search
Sponsored Links
N4 Pharma PLC Company Snapshot
N4 Pharma PLC operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares N4 Pharma PLC with three other pharmaceutical manufacturers in Europe: Kancera AB of SWEDEN (2018 sales of 358,000.00 Swedish Kronor [US$40,629.42 ] of which 100% was Operations), Vicore Pharma Holding AB of SWEDEN (508,000.00 Swedish Kronor [US$57,652.92 ] of which 100% was HVB), and Elanix Biotechnologies AG which is based in GERMANY (61,753.00 Euros [US$72,993.90 ] of which 100% was Cosmetic ointments).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
N4 Pharma PLC
  Stock Performance Chart for N4 Pharma PLC
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): 9.60p
(Figures in Pounds Sterling)
1 Week -6.3%   13 Weeks -13.7%  
4 Weeks 113.3%   52 Weeks 209.7%  
N4 Pharma PLC Key Data:
  Ticker: N4P Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 72,832
(Year Ending Jan 2019).
Employees: 4
  Currency: Pounds Sterling Market Cap: 9,740,404
  Fiscal Yr Ends: December Shares Outstanding: 101,462,537
  Share Type: Ordinary Closely Held Shares: 35,338,800
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.